Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 1.19x is 28% below its estimated 5-year average of 1.64x, near the low end of its estimated 5-year range (1.04x–3.23x).
As of 2026-10-06T18:53:35.962Z. 9.91% below its estimated 12-month average of 1.32x.
Calculation as of: 2026-10-06T18:53:35.962Z.
Quote observation: 2026-10-06T18:50:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5ba1a7ae2545dd241011b344210ba2dd7fcd9a347687a5f40438e3bec48b98ab
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
1.19x
EV/SALES RATIO AVG TTM
1.32x
EV/SALES RATIO AVG 3Y
1.47x
EV/SALES RATIO AVG 5Y
1.64x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.91%
CURRENT VS 3Y AVG
-18.88%
CURRENT VS 5Y AVG
-27.66%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.40x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
-72.95%
vs the sector median at left
Viemed Healthcare, Inc.
Market Cap
$357.08M
EV/Sales Ratio
1.19x
TTM Avg
1.32x
3Y Avg
1.47x
5Y Avg
1.64x
Market Cap
$356.36M
EV/Sales Ratio
5.80x
TTM Avg
7.29x
3Y Avg
5.92x
5Y Avg
7.97x
Market Cap
$357.88M
EV/Sales Ratio
N/A
TTM Avg
50.09x
3Y Avg
50.09x
5Y Avg
50.09x
Market Cap
$359.18M
EV/Sales Ratio
5.37x
TTM Avg
5.77x
3Y Avg
8.21x
5Y Avg
104.30x
Market Cap
$353.41M
EV/Sales Ratio
12.63x
TTM Avg
33.06x
3Y Avg
53.36x
5Y Avg
138.77x
Market Cap
$348.23M
EV/Sales Ratio
N/A
TTM Avg
102877.97x
3Y Avg
102877.97x
5Y Avg
102877.97x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Viemed Healthcare, Inc. (VMD) | $357.08M | 1.19x | 1.32x | 1.47x | 1.64x |
| Embecta Corp. (EMBC)vs › | $357.66M | 1.61x | 1.60x | 1.83x | 2.04x |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $356.36M | 5.80x | 7.29x | 5.92x | 7.97x |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $357.88M | N/A | 50.09x | 50.09x | 50.09x |
| Ocugen, Inc. (OCGN)vs › | $357.76M | 75.48x | 97.80x | 57.72x | 64.32x |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.18M | 5.37x | 5.77x | 8.21x | 104.30x |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $353.41M | 12.63x | 33.06x | 53.36x | 138.77x |
| Turn Therapeutics Inc. (TTRX)vs › | $352.39M | N/A | N/A | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $348.23M | N/A | 102877.97x | 102877.97x | 102877.97x |
| Opus Genetics, Inc. (IRD)vs › | $366.18M | 31.69x | 114.38x | 98.11x | 98.11x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 1.26x |
| 2026-10-02 | 1.25x |
| 2026-10-01 | 1.24x |
| 2026-09-30 | 1.24x |
| 2026-09-29 | 1.26x |
| 2026-09-28 | 1.25x |
| 2026-09-25 | 1.22x |
| 2026-09-24 | 1.21x |
| 2026-09-23 | 1.20x |
| 2026-09-22 | 1.22x |
| 2026-09-21 | 1.21x |
| 2026-09-18 | 1.22x |
| 2026-09-17 | 1.22x |
| 2026-09-16 | 1.22x |
| 2026-09-15 | 1.20x |
| 2026-09-14 | 1.21x |
| 2026-09-11 | 1.20x |
| 2026-09-10 | 1.20x |
| 2026-09-09 | 1.20x |
| 2026-09-08 | 1.20x |
| 2026-09-04 | 1.24x |
| 2026-09-03 | 1.23x |
| 2026-09-02 | 1.23x |
| 2026-09-01 | 1.20x |
| 2026-08-31 | 1.21x |
| 2026-08-28 | 1.21x |
| 2026-08-27 | 1.23x |
| 2026-08-26 | 1.28x |
| 2026-08-25 | 1.24x |
| 2026-08-24 | 1.24x |
| 2026-08-21 | 1.21x |
| 2026-08-20 | 1.17x |
| 2026-08-19 | 1.22x |
| 2026-08-18 | 1.25x |
| 2026-08-17 | 1.24x |
| 2026-08-14 | 1.26x |
| 2026-08-13 | 1.25x |
| 2026-08-12 | 1.27x |
| 2026-08-11 | 1.27x |
| 2026-08-10 | 1.27x |
| 2026-08-07 | 1.33x |
| 2026-08-06 | 1.30x |
| 2026-08-05 | 1.34x |
| 2026-08-04 | 1.34x |
| 2026-08-03 | 1.66x |
| 2026-07-31 | 1.66x |
| 2026-07-30 | 1.67x |
| 2026-07-29 | 1.66x |
| 2026-07-28 | 1.69x |
| 2026-07-27 | 1.72x |
| 2026-07-24 | 1.67x |
| 2026-07-23 | 1.66x |
| 2026-07-22 | 1.69x |
| 2026-07-21 | 1.69x |
| 2026-07-20 | 1.70x |
| 2026-07-17 | 1.73x |
| 2026-07-16 | 1.72x |
| 2026-07-15 | 1.69x |
| 2026-07-14 | 1.70x |
| 2026-07-13 | 1.75x |
| 2026-07-10 | 1.75x |
| 2026-07-09 | 1.74x |
| 2026-07-08 | 1.72x |
| 2026-07-07 | 1.71x |
| 2026-07-06 | 1.72x |
| 2026-07-02 | 1.71x |
| 2026-07-01 | 1.67x |
| 2026-06-30 | 1.62x |
| 2026-06-29 | 1.62x |
| 2026-06-26 | 1.65x |
| 2026-06-25 | 1.66x |
| 2026-06-24 | 1.63x |
| 2026-06-23 | 1.56x |
| 2026-06-22 | 1.55x |
| 2026-06-18 | 1.51x |
| 2026-06-17 | 1.50x |
| 2026-06-16 | 1.47x |
| 2026-06-15 | 1.48x |
| 2026-06-12 | 1.49x |
| 2026-06-11 | 1.48x |
| 2026-06-10 | 1.44x |
| 2026-06-09 | 1.41x |
| 2026-06-08 | 1.41x |
| 2026-06-05 | 1.42x |
| 2026-06-04 | 1.40x |
| 2026-06-03 | 1.36x |
| 2026-06-02 | 1.35x |
| 2026-06-01 | 1.38x |
| 2026-05-29 | 1.40x |
| 2026-05-28 | 1.42x |
| 2026-05-27 | 1.41x |
| 2026-05-26 | 1.37x |
| 2026-05-22 | 1.37x |
| 2026-05-21 | 1.37x |
| 2026-05-20 | 1.38x |
| 2026-05-19 | 1.37x |
| 2026-05-18 | 1.37x |
| 2026-05-15 | 1.33x |
| 2026-05-14 | 1.35x |
| 2026-05-13 | 1.35x |
| 2026-05-12 | 1.33x |
| 2026-05-11 | 1.29x |
| 2026-05-08 | 1.27x |
| 2026-05-07 | 1.31x |
| 2026-05-06 | 1.21x |
| 2026-05-05 | 1.45x |
| 2026-05-04 | 1.42x |
| 2026-05-01 | 1.49x |
| 2026-04-30 | 1.49x |
| 2026-04-29 | 1.48x |
| 2026-04-28 | 1.50x |
| 2026-04-27 | 1.48x |
| 2026-04-24 | 1.44x |
| 2026-04-23 | 1.42x |
| 2026-04-22 | 1.42x |
| 2026-04-21 | 1.38x |
| 2026-04-20 | 1.44x |
| 2026-04-17 | 1.46x |
| 2026-04-16 | 1.43x |
| 2026-04-15 | 1.44x |
| 2026-04-14 | 1.45x |
| 2026-04-13 | 1.45x |
| 2026-04-10 | 1.42x |
| 2026-04-09 | 1.42x |
| 2026-04-08 | 1.47x |
| 2026-04-07 | 1.44x |
| 2026-04-06 | 1.46x |
| 2026-04-02 | 1.44x |
| 2026-04-01 | 1.43x |
| 2026-03-31 | 1.38x |
| 2026-03-30 | 1.40x |
| 2026-03-27 | 1.38x |
| 2026-03-26 | 1.38x |
| 2026-03-25 | 1.40x |
| 2026-03-24 | 1.38x |
| 2026-03-23 | 1.37x |
| 2026-03-20 | 1.30x |
| 2026-03-19 | 1.38x |
| 2026-03-18 | 1.39x |
| 2026-03-17 | 1.45x |
| 2026-03-16 | 1.46x |
| 2026-03-13 | 1.38x |
| 2026-03-12 | 1.36x |
| 2026-03-11 | 1.36x |
| 2026-03-10 | 1.42x |
| 2026-03-09 | 1.39x |
| 2026-03-06 | 1.31x |
| 2026-03-05 | 1.26x |
| 2026-03-04 | 1.50x |
| 2026-03-03 | 1.48x |
| 2026-03-02 | 1.46x |
| 2026-02-27 | 1.44x |
| 2026-02-26 | 1.42x |
| 2026-02-25 | 1.42x |
| 2026-02-24 | 1.39x |
| 2026-02-23 | 1.37x |
| 2026-02-20 | 1.36x |
| 2026-02-19 | 1.37x |
| 2026-02-18 | 1.39x |
| 2026-02-17 | 1.38x |
| 2026-02-13 | 1.37x |
| 2026-02-12 | 1.35x |
| 2026-02-11 | 1.40x |
| 2026-02-10 | 1.37x |
| 2026-02-09 | 1.40x |
| 2026-02-06 | 1.43x |
| 2026-02-05 | 1.42x |
| 2026-02-04 | 1.34x |
| 2026-02-03 | 1.31x |
| 2026-02-02 | 1.32x |
| 2026-01-30 | 1.27x |
| 2026-01-29 | 1.24x |
| 2026-01-28 | 1.23x |
| 2026-01-27 | 1.24x |
| 2026-01-26 | 1.23x |
| 2026-01-23 | 1.22x |
| 2026-01-22 | 1.23x |
| 2026-01-21 | 1.24x |
| 2026-01-20 | 1.21x |
| 2026-01-16 | 1.22x |
| 2026-01-15 | 1.25x |
| 2026-01-14 | 1.21x |
| 2026-01-13 | 1.21x |
| 2026-01-12 | 1.21x |
| 2026-01-09 | 1.20x |
| 2026-01-08 | 1.20x |
| 2026-01-07 | 1.21x |
| 2026-01-06 | 1.21x |
| 2026-01-05 | 1.21x |
| 2026-01-02 | 1.20x |
| 2025-12-31 | 1.23x |
| 2025-12-30 | 1.25x |
| 2025-12-29 | 1.24x |
| 2025-12-26 | 1.21x |
| 2025-12-24 | 1.21x |
| 2025-12-23 | 1.21x |
| 2025-12-22 | 1.22x |
| 2025-12-19 | 1.23x |
| 2025-12-18 | 1.25x |
| 2025-12-17 | 1.23x |
| 2025-12-16 | 1.21x |
| 2025-12-15 | 1.22x |
| 2025-12-12 | 1.20x |
| 2025-12-11 | 1.21x |
| 2025-12-10 | 1.22x |
| 2025-12-09 | 1.16x |
| 2025-12-08 | 1.14x |
| 2025-12-05 | 1.13x |
| 2025-12-04 | 1.13x |
| 2025-12-03 | 1.13x |
| 2025-12-02 | 1.11x |
| 2025-12-01 | 1.15x |
| 2025-11-28 | 1.15x |
| 2025-11-26 | 1.15x |
| 2025-11-25 | 1.17x |
| 2025-11-24 | 1.14x |
| 2025-11-21 | 1.11x |
| 2025-11-20 | 1.06x |
| 2025-11-19 | 1.05x |
| 2025-11-18 | 1.06x |
| 2025-11-17 | 1.05x |
| 2025-11-14 | 1.07x |
| 2025-11-13 | 1.07x |
| 2025-11-12 | 1.09x |
| 2025-11-11 | 1.06x |
| 2025-11-10 | 1.07x |
| 2025-11-07 | 1.07x |
| 2025-11-06 | 1.05x |
| 2025-11-05 | 1.04x |
| 2025-11-04 | 1.06x |
| 2025-11-03 | 1.07x |
| 2025-10-31 | 1.05x |
| 2025-10-30 | 1.04x |
| 2025-10-29 | 1.06x |
| 2025-10-28 | 1.12x |
| 2025-10-27 | 1.13x |
| 2025-10-24 | 1.13x |
| 2025-10-23 | 1.11x |
| 2025-10-22 | 1.11x |
| 2025-10-21 | 1.11x |
| 2025-10-20 | 1.11x |
| 2025-10-17 | 1.08x |
| 2025-10-16 | 1.11x |
| 2025-10-15 | 1.12x |
| 2025-10-14 | 1.12x |
| 2025-10-13 | 1.12x |
| 2025-10-10 | 1.11x |
| 2025-10-09 | 1.12x |
| 2025-10-08 | 1.12x |
| 2025-10-07 | 1.12x |
| 2025-10-06 | 1.12x |
| 2025-10-03 | 1.13x |
| 2025-10-02 | 1.12x |
| 2025-10-01 | 1.13x |
| 2025-09-30 | 1.10x |
| 2025-09-29 | 1.07x |
| 2025-09-26 | 1.09x |
| 2025-09-25 | 1.08x |
| 2025-09-24 | 1.10x |
| 2025-09-23 | 1.10x |
Showing the most recent 260 of 2,171 data points. The chart above shows the full history.
